Report an error

Spotted something inaccurate in “SGLT2i Cuts CKD Composite Risk 24% vs RAS Inhibitors in 36,000-Patient Study”? Tell us what’s wrong and we’ll check it against the original source.

Website

Send report Cancel

This form is for factual corrections. We read every report but cannot reply individually.